RxDoctor Payments Data

Rhonda Cottino, PA

Physician Assistant · Winchester, VANPI 1447742291

Payments from drug & device makers

$1,148in general payments, 2019–2025

Across 46 payments — averaging $24.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$186
  • Medtronic$157
  • Radius Health, Inc.$142
  • Sanofi-aventis U.S. LLC$105
  • Amgen$87
  • Dexcom, Inc.$86
  • plus $386 from 12 others

What the payments were for

  • Food & beverage$1,07694%
  • Education$726%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,148 in reported general payments places this provider in the 75th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$31,172
Medicare patients
83
Services billed
413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide140$277,101
TrulicityDulaglutide102$178,522
MounjaroTirzepatide102$147,696
JardianceEmpagliflozin96$138,947
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/752$91,737
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt37$45,035
Tresiba Flextouch U-100Insulin Degludec51$37,342
Tresiba Flextouch U-200Insulin Degludec16$36,352
Lantus SolostarInsulin Glargine,hum.Rec.Anlog165$28,866
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog30$27,155
Humalog Kwikpen U-100Insulin Lispro48$25,716
FarxigaDapagliflozin Propanediol11$18,204
Novolog FlexpenInsulin Aspart55$16,434
Humulin R U-500Insulin Regular, Human11$14,511
Fiasp FlextouchInsulin Aspart (Niacinamide)12$14,272

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Baqsimi, Humalog$83$340,088243 claims
Novo NordiskOzempic, Novolog$186$288,881169 claims
Boehringer IngelheimJardiance$32$138,94796 claims
AstraZenecaFarxiga$73$18,20411 claims
AbbVieSynthroid$30$2,15838 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Winchester

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →